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Objectives: Thoracic endografts (stent grafts) have emerged as a less invasive modality to treat various thoracic aortic
lesions. The intentional coverage of the left subclavian artery (LSA) during the placement of these endografts is associated
with several complications including stroke, spinal cord ischemia, and arm ischemia. In this review, we synthesize the
available evidence regarding the complications associated with LSA coverage.
Methods: We searched electronic databases (MEDLINE and EMBASE) from January 1990 through February 2008 for
studies that included patients who received thoracic endografts and had intentional LSA coverage. Eligible studies had a
control group that either received the endograft without LSA coverage or had primary revascularization prior to
coverage. Two independent reviewers determined trial eligibility and extracted descriptive, methodological and outcome
data from each eligible study.Meta-analyses estimated Peto odds ratio (OR) and 95% confidence intervals (CI) to describe
the strength of association between coverage and complications; the I2 statistic described the proportion of inconsistency
of treatment effect among studies not due to chance.
Results: We found 51 eligible observational studies. LSA coverage was associated with significant increase in the risk of
arm ischemia (OR 47.7; CI, 9.9-229.3; I2 72%, 19 studies) and vertebrobasilar ischemia (OR 10.8; CI, 3.17-36.7; I2
0%; eight studies); and nonsignificant increase in the risk of spinal cord ischemia (OR 2.69; CI, 0.75-9.68; I2 40%; eight
studies) and anterior circulation stroke (OR 2.58; CI, 0.82-8.09; I2  64%, 13 studies). There were no significant
associations between LSA coverage and death, myocardial infarction, or transient ischemic attacks. The incidence of
phrenic nerve injury as a complication of primary revascularization was 4.40% (CI, 1.60%-12.20%). Data on perioperative
infection were sparse and rarely reported.
Conclusions: Very low quality evidence suggests that LSA coverage increases the risk of arm ischemia, vertebrobasilar
ischemia, and possibly spinal cord ischemia and anterior circulation stroke. (J Vasc Surg 2009;50:1159-69.)Over the past decade, the use of thoracic endografts
(stent grafts) has emerged as a less invasive modality to treat
various thoracic aortic pathologies, including aneurysm,
dissection, trauma, fistula, and penetrating ulcer. To ex-
pand the anatomic limits of this technology, intentional
coverage of the left subclavian artery with the proximal
aspect of the endograft without revascularization (carotid-
subclavian artery bypass or transposition) has been per-
formed.
Intentional covering of the left subclavian artery may
lead to a higher incidence of extremity ischemia, spinal cord
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doi:10.1016/j.jvs.2009.09.002ischemia, or stroke. A few studies report that intentional
coverage without revascularization is not associated with
additional morbidity,1-3 whereas other studies report a
higher incidence of postoperative arm ischemia and poste-
rior circulation strokes compared with patients that did not
undergo intentional coverage.4,5 The discrepancy in the
outcomes of intentional LSA coverage may be due to the
primary etiology being treated, underlying patient comor-
bidities, or other patient and/or anatomic factors.
The Society for Vascular Surgery has formed a commit-
tee of experts in the treatment of thoracic aortic lesions to
formulate clinical practice guidelines to guide patients and
surgeons in making treatment decisions. This committee
commissioned us to conduct a systematic review and meta-
analysis to support the formulation of evidence-based rec-
ommendations. Thus, we sought to summarize the best
available evidence about the effect of intentional LSA cov-
erage on patients’ morbidity and mortality.
METHODS
The report of this protocol-driven systematic review
was approved by the Committee on Thoracic Aortic Dis-
ease from the Society for Vascular Surgery and is in adher-
ence with the standards for reporting Meta-analyses of
1159
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quality of evidence was rated using the Grading of Rec-
ommendations Assessment, Development, and Evalua-
tion (GRADE) methods.7
Eligibility criteria
Eligible studies were controlled studies that enrolled
patients receiving an endovascular device to repair descend-
ing thoracic aortic pathologies such as transection, aneu-
rysm or dissection. Eligible studies enrolled patients in
whom the LSA was intentionally covered to extend the
proximal seal-zone for endovascular repair. Eligible studies
included a comparison group including patients in whom
the endograft placement did not cover the LSA or patients
who underwent a primary revascularization procedure such
as carotid-subclavian bypass or transposition.
We included studies that measured the outcomes of
interest including death, arm ischemia, vertebrobasilar isch-
emia, anterior circulation stroke, transient ischemic attack
(TIA), spinal cord ischemia, myocardial infarction, phrenic
nerve paralysis, and infection. We defined spinal cord isch-
emia as permanent decrease or loss of lower extremity
neurological function in the immediate postoperative pe-
riod. Vertebrobasilar ischemia was defined as permanent
loss of neurological function related to the posterior circu-
lation. Arm ischemia was defined as any symptoms of hand
ischemia that occurred at rest or with arm exertion and
required revascularization. Studies were included regard-
less of their language, sample size, or duration of patient
follow-up. Single cohort studies (ie, studies in which all
patients received coverage without a concurrent compari-
son group) were excluded.
Study identification
An expert reference librarian (P.J.E) designed and con-
ducted the electronic search strategy with input from study
investigators with expertise in conducting systematic re-
views. To identify eligible studies, we searched electronic
databases (MEDLINE and EMBASE) from January 1990
through February 2008. We chose the year 1990 as the
start point for literature search because the use of thoracic
endografts started in the late 1990s in Europe and in the
early 2000s in the US; and because surgical techniques,
device technology, and peri-operative care have likely
changed sufficiently to decrease the relevancy of literature
published prior to this date.We also sought references from
experts, bibliographies of included trials, and the ISI (In-
stitute for Scientific Information) Science Citation Index
for publications that cited included studies.
MeSH and EMBASE subject headings were primarily
used to describe the aorta, with subheadings to focus upon
surgery or repair: aorta, thoracic/sugery, therapy, aortic
surgery, therapy, aortic aneurysm/surgery, therapy, aortic
disease, or aorta dissecting aneurysm or aortic rupture. A
combination of subject headings and text words were used
for the type of intervention: stent* or stentgraft, in con-
junction with endograft, endovascul*, endolumin*, in-
tralumin*, endoprosth*, blood vessel prosthesis implanta-tion, or blood vessel prosthesis. Text words were used to
describe the placement: covered, uncovered, anchor*,
planned within 2 words of transpos*, subclavian*, lsa. The
outcomes of concern (risk*, postoperative complications,
mortality, brain ischemia, cerebrovascular accident, cere-
brovascular trauma, hypoxia, intracranial embolis and
thrombosis, bacterial infections, intracranial hemorrhages,
or paralysis) were combined with all terms, and limited to
clinical trials, comparative studies, practice guidelines, and
other clinical studies. Detailed search strategy is available
from study authors upon request.
Paired reviewers working independently screened all
titles and abstracts for eligibility. References that were
deemed potentially relevant were retrieved in full text for
full text evaluation against eligibility criteria. The chance
adjusted inter-reviewer agreement (kappa statistic) about
study eligibility was 0.96 (95% confidence interval (CI)
0.96-1.0). Disagreements were resolved by consensus (the
two reviewers discussed the study and reached a consen-
sus), and when disagreement continued, by arbitration (a
third reviewer adjudicated the study).
Data collection
Two reviewers working independently and using a
standardized form extracted data from all eligible studies.
We extracted descriptive data (number of patients in each
study arm, patients’ age, gender, indication for endograft
placement, urgency of procedure, control group descrip-
tion, type of endograft, comorbidities such as diabetes,
coronary artery disease, hypertension, and history of a
previous stroke); methodological data (study design, ran-
domization procedures if any, bias protection measures,
proportions of patients lost to follow up, funding source,
the prognostic comparability of the two study groups,
ascertainment of exposure and outcome, and blinding of
outcome assessors); and outcome data (death, arm isch-
emia, vertebrobasilar ischemia, anterior circulation stroke,
TIA, spinal cord ischemia, myocardial infarction, phrenic
nerve paralysis, and infection). We contacted authors of
included studies by e-mail for clarification and to obtain
missing data.
Statistical analysis
Meta-analyses. Anticipating that studies will have rare
events and report sparse data, we used Peto odds ratio
(OR)8 as the measure of effect for dichotomous outcomes
and estimated the 95% confidence intervals (CI) for each
outcome to reflect the uncertainty of point estimates of
effect. When data are sparse and events are rare, Peto odds
ratio method is associated with less bias, more power, and
better confidence interval coverage than other methods,
provided that study arms are balanced and treatment effects
are not large,9 which we anticipated to be the case in this
meta-analysis. In this review, OR of 1.0 indicates no asso-
ciation between LSA coverage and a particular outcome
whereas OR above 1.0 indicates that coverage without
revascularization increased the risk for this outcome. If
the confidence interval of the OR overlaps the value of
s of st
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cally significant.
We used the I2 statistic, which estimates the percentage
of heterogeneity across studies that is due to heterogeneity
rather than chance (ie, the percentage of variability in
treatment effects across trials that is not due to chance or
random error, but rather due to real differences in study
patients, design or interventions).10 I2 values of  25%,
50%, and 75% represent low, moderate, and high incon-
sistency, respectively. Statistical analysis was conducted us-
ing Comprehensive Meta-Analysis, Version 2 (Biostat Inc.,
Englewood, New Jersey, USA).
Subgroup and sensitivity analyses. We established a
priori hypotheses to explore subgroup interactions and
explain inconsistency in the direction and magnitude of
effect among studies. These subgroup analyses were based
on the indication for aortic repair (aneurysm vs. dissection
vs. transsection) and the urgency of repair (urgent vs.
elective), and the control intervention (no coverage vs.
coverage after primary revascularization). We tested the
hypotheses of a subgroup effect using a test of interac-
tion.11 We also planned to conduct meta-regression using
the effect size as the dependent outcome variable and the
duration of follow up as the independent continuous
variable.
Anticipating that the outcomes of interest would be
rare and that many studies would report zero events in both
arms, we planned to conduct sensitivity analysis using the
risk difference (RD) as the measure of effect. RD value of 0
indicates that the absolute risk of a particular outcome is
similar between the two study arms. RD 0 indicates that
coverage without revascularization increased the risk for
this outcome. If the confidence interval of the RD overlaps
the value of 0, this would indicate that the results are not
statistically significant.
Using RD allows the inclusion of these “no event”
studies, which increases sample size, improves precision,
and includes the totality of evidence in generating meta-
analytic estimates. RD has the shortcomings of being asso-
ciated with higher inconsistency among studies and is very
dependent on the control group event rates in the different
studies.12,13 We planned to explore whether study conclu-
Fig 1. Processions were sensitive to the choice of outcomemeasure used.RESULTS
Study identification
Fig 1 depicts our search and selection procedures.
Table I summarizes the characteristics of the 51 eligible
studies in terms of patients’ age, gender, comorbidities,
type of endograft, indications for placement, and elements
of study quality. These studies enrolled 3365 patients with
a mean study size of 70 patients. The majority of patients
(75%) were males and the mean age was 58 years.
Study quality
All eligible studies were observational, comprising five
prospective cohort studies and 46 retrospective chart re-
views. Researchers ascertained the outcomes, which were
mostly death or major morbidities, and the exposure, by
reviewing medical charts and perioperative records. Re-
viewers determining the quality of the eligible studies had
perfect agreement on study design, exposure and outcome
ascertainment; however, the prognostic comparability of
study cohorts at baseline was difficult to assess because
there were multiple indications for endograft placement
and these indications conferred variable prognosis given in
part by the original aortic pathology regardless of the
procedure patients received. Loss of follow-up was in gen-
eral low and only exceeded 10% in two studies. Study
funding was often not reported but on two occasions was
provided by endograft manufacturers.14,15 Outcomes were
poorly described in the included studies and we had to
accept the definitions of the original studies; therefore, it
was not always clear whether cases of spinal cord, vertebro-
basilar, and hand ischemia were permanent or that they
required interventions/revascularization.
Meta-analysis
LSA coverage was associated with significant increase in
the risk of arm ischemia (OR 47.69; CI, 9.92-229.34; I2
72%, 19 studies; Fig 2) and vertebrobasilar ischemia (OR
10.78; CI, 3.17-36.69; I2  0%; eight studies; Fig 3); and
nonsignificant increase in the risk of spinal cord ischemia
(OR 2.69; CI, 0.75-9.68; I2  40%; eight studies; Fig 4)
and anterior circulation stroke (OR 2.58; CI, 0.82-8.09;
udy selection.I2  64%, 13 studies; Fig 5).
JOURNAL OF VASCULAR SURGERY
November 20091162 Rizvi et alTable I. Description of included studies
Author, Year No. Endograft Indication
Age
(Years)
%
Females
%
CAD
Mitchell 199618 44 Homemade device Trauma (4), pseudo aneurysm (4), aneurysm (24),
penetrating ulcer (8), ductus aneurysm (4),
dissection (1); all elective
66 18 50
Kato 199719 10 Homemade device Trauma; 7 urgent 56 40 NR
Hausegger
200120
29 Talent Dissection; elective 55-81 3 3
Criado 200221 47 Talent Aneurysm (31), dissection (16) 33-88 30 NR
Fattori 200222 19 TAG (18), Talent (1) Trauma; Urgent (11), delayed (8) 39 NR NR
Orend 200223 8 Talent, TAG Trauma and urgent 17-59 0 NR
Pamler 200224 14 TAG, Talent Dissection; urgent (1), elective (13) 60 14 43
Totaro 200225 32 TAG Dissection (25), aneurysm (7); urgent (5),
elective (25)
62 31 NR
Balzer 200326 26 TAG, Talent Aneurysm (18), dissection (8) 61 46 12
Lambrechts
200327
26 Aneurx (1), Talent (13), TAG
(12)
Trauma (3), Dissection (11), Aneurysm (12) 64 69 19
Matravers
200328
24 TAG, Talent, Aneurx Aneurysm, dissection, penetrating ulcer,
pseudoaneurysm
71 NR NR
Orford 200329 9 Zenith Trauma; elective (1), urgent (8) 52 33 NR
Scharrer-Palmer
200330
45 Talent, TAG, Corvita, Aneurx,
Vangaurd
Aneurysms; urgent (11), elective (34) 69 27 NR
Sunder-Plassman
200331
45 Aneurx, Talent, TAG, Aneurysms; elective (30), urgent (15) 69 27 NR
Tiesenhausen
200332
10 Talent, TAG dissection (7), aneurysm (3) NR NR NR
Amabile 200433 9 Talent, TAG Trauma; delayed 6, urgent 3 15-51 11 NR
Leurs 200434 443 Talent, TAG, Zenith, Endofit Aneurysm (249), dissection (131),
pseudoaneurysm (13), Trauma (50); Elective
(263), Urgent (180)
63 25 17
Nemes 200435 31 Vangaurd, Talent Aneurysms 60 35 NR
Tse 200436 34 NR Trauma, dissection, aneurysm 73 54 46
Dagenais 200537 24 Talent Aneurysm (10), penetrating ulcer (6), trauma (4),
dissection (2), fistula (1), psuedoaneurysm (1);
Urgent (3), elective (21)
63 33 33
Dong 200538 10 Talent Dissection (9), aneurysm (1) 42-65 NR 40
Doss 200539 32 Talent, TAG Ruptured aneurysm (15), perforated dissection
(10), Trauma (7)
61 47 22
Fu 200540 10 Talent Dissection (9), aneurysm (1) 45 30 90
Guo 200541 178 Talent Dissection; acute (76), chronic (102) 50 17 NR
Lawlor 200542 7 Talent Trauma; all urgent 42 14 NR
Melissano
200543
21 Talent, TAG, Zenith,
Endomed
Aneurysm, dissection, trauma; all elective 71 17 NR
Pogorzekski
200544
42 NR Dissection 22-81 NR NR
Amabile 200645 17 Talent or TAG Trauma and aneurysm; elective (7), Urgent (10) 42 12 NR
Caronno 200646 19 TAG (12), Talent (4), Zenith
(3)
Trauma (7), dissection (5), penetrating ulcer (4),
symptomatic aneurysm (3); all urgent
54 10 16
Ferrari 200647 18 Talent Trauma; all urgent 41 NR NR
Kaya 200648 28 Talent (26), TAG (2) Dissection (12), intramural hematoma (4),
ruptured aneurysm (7), trauma (2), fistula (2),
penetrating ulcer (1); all urgent
64 39 14
Marchiex 200649 45 Talent (27), TAG (17) Aneurysm; elective (37), Urgent (8) 68 NR 53
Patel 200650 73 Talent, TAG, Zenith, Aneurx Aneurysm, dissection, trauma 67 NR 43
Petersen 20064 30 NR Aneurysm, dissection, trauma; 2 had abberrant
subclavian origins underwent prior subclavian
transposition
58 37 NR
Schoder 200651 58 Talent (30), TAG (27),
Endofit (1)
Aneurysm (32), Dissection (20), trauma (4),
penetrating ulcer (2); Urgent (19), elective (39)
62 22 12
Song 200614 42 Aneurx (5), Talent (37) Thoracic dissection; Elective (17), Urgent (28) 64 43 21
Verhoye 200652 54 Talent, TAG Zenith NR 63 19 NR
Buth 200753 606 Talent (386), TAG (119),
Zenith (39), Valiant (28),
Endofit (12), Aneurx (4),
Aneurysm (291), dissection (215),
pseudoaneurysm (24), trauma (67); chronic
(379), acute (205), unknown (22)
63 22 25Relay (2), unknown (16)
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% HTN % Renal failure % Previous stroke % DM F/U (Months) % Loss to F/U Funding Design
82 14 NR 18 13 0 NR OB, R, S
NR NR NR NR 15 0 NR OB, R, S
100 3 3 NR 2-36 0 NR OB, R, S
NR NR NR NR 18 6 NR OB, R, S
NR NR NR NR 20 0 NR OB, R, S
NR NR NR NR 11 0 NR OB, R, S
83 NR NR 43 14 NR NR OB, R, S
NR NR NR NR 12 0 NR OB, R, S
85 12 8 NR UC 0 NR OB, R, S
69 23 12 4 UC NR NR OB, R, S
NR NR NR NR UC NR NR OB, R, S
NR NR NR NR 21 0 NR OB, R, S
NR NR NR NR 24 NR NR OB, R, S
NR NR NR NR UC NR NR OB, R, S
NR NR NR NR UC NR NR OB, R, S
NR NR NR NR 15 0 NR OB, R, S
NR NR NR NR UC 66 NFP OB, P, M
NR NR NR NR UC NR NR OB, R, S
73 24 5 22 10 NR NR OB, R, S
67 25 NR 17 13 0 NR OB, R, S
10 of 10 NR 10 30 3-12 0 NR OB, R, S
44 6 NR NR 36 NR NR OB, R, S
NR NR NR 20 UC NR NR OB, R, S
NR NR NR NR 9 10 NR OB, R, S
NR NR NR NR 18 14 NR OB, R, S
NR NR NR NR 23 NR NR OB, R, S
100 NR NR NR UC NR NR OB, R, S
NR NR NR NR 13 6 NR OB, R, S
63 16 10 NR 25 NR NR OB, R, S
NR NR NR NR 21 NR NR OB, R, S
68 29 NR NR 11 0 NR OB, R, S
76 22 9 27 25 2 NR OB, P, S
63 17 NR 11 23 0 NR OB, R, S
NR NR NR NR 18 NR NR OB, P, S
74 26 3 21 22 2 NR OB, R, S
88 10 of 42 10 10 11 12 FP OB, R, S
NR NR NR NR 23 0 NR OB, R, S
69 18 NR 10 UC NR NR OB, P, M
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death (OR 1.14; CI, 0.49-2.67; I2  28%, 17 studies),
myocardial infarction (OR 0.47; CI, 0.02-9.26; I2  11%,
two studies), or TIA (OR 0.94; CI, 0.19-4.74; I2  12%,
six studies). The incidence of phrenic nerve injury as a
complication of primary revascularization was 4.40% (CI,
1.60%-12.20%). The baseline risks of outcomes of interest
in patients who underwent LSA coverage are presented in
Table II. Data on perioperative infection were sparse and
rarely reported.
Subgroup and sensitivity analysis
When RD was used as the measure of effect instead of
Peto OR, study conclusions did not change in terms of the
outcomes of death (RD0.49%; CI,3.94%-2.96%; I2
0%, 32 studies), myocardial infarction (RD 0.45%; CI,
3.41%-2.52%; I2  0%, 31 studies), anterior circulation
stroke (RD 1.76%; CI, 0.45%-3.97%; I2  0%, 40 stud-
ies), TIA (RD 0.15%; CI, 2.07%-1.76%; I2  0%, 41
studies), spinal cord ischemia (RD 1.18%; CI, 0.79%-
3.14%, I2  0%, 47 studies) or arm ischemia (RD 2.14%;
CI, 0.15%-4.13%; I2  4%, 31 studies). However, the
outcome of vertebrobasilar ischemia became less precise
due to the inclusion of numerous studies with zero events
in both arms (RD 0.64%; CI, 1.15%-2.43%).
We found no significant subgroup interactions across
Table I. Continued
Author, Year No. Endograft
Feezor 200754 196 TAG (156) Aneury
electi
Ferreira 200755 81 NR aneurys
Juszkat 200756 13 NR pseudo
urgen
McPhee 200757 8 Anuerx and Gore Trauma
Neschis 200758 20 Talent, Aneurx and Gore Trauma
Orend 200759 36 TAG (23), Zenith (6),
Talent (5)
Trauma
Reece 20075 64 Aneurx, Talent, TAG aneurys
Rehders 200460 171 Talent dissecti
pseud
Riesenmen
20071
24 Talent, TAG, Zenith trauma,
aorto
note
in da
Rodriguez
200761
324 TAG Aneury
ulcer
aorto
(100
Saratzis 200762 9 Endofit Trauma
Thompson
200715
180 Valiant Aneury
acute
traum
Woo 20083 70 TAG, Talent, TX2 Aneury
pseuo
aneu
and 2subgroups defined by whether the aortic intervention wasdone on an urgent or elective basis or whether the indica-
tion for the intervention was aneurysm or dissection. Data
on trauma/transsection was insufficient for subgroup anal-
ysis. When we tested for subgroup interaction based on the
control group in the included studies (patients received
aortic endograft without coverage vs. they received primary
revascularization before coverage), we found no significant
interaction for all outcomes except arm ischemia (P value
for interaction  0.01). This interaction means that the
magnitude of increased risk of arm ischemia due to LSA
coverage was greater when coverage is compared with no
coverage; than when coverage is compared with coverage
preceded by primary revascularization. Several other sub-
group analyses were not conducted due to insufficient
data. Table III depicts all these subgroup analyses. Meta-
regression showed no significant association between the
length of study follow-up (expressed in days) and out-
comes of interest (P  .05 for all outcomes).
DISCUSSION
Our findings
We conducted a systematic review of the literature to
evaluate the effect of the intentional coverage of the left
subclavian artery associated with endograft placement in
Indication
Age
(Years)
%
Females
%
CAD
auma, dissection, pseudoaneurysm;
38), urgent (30)
NR NR NR
ssection, penetrating ulcer NR NR NR
ysm (6), dissection (3), trauma (4);
, elective (6)
21-56 30 NR
rgent 31 NR NR
rgent 40 15 NR
rgent 17-79 13 NR
auma, dissection, pseudoaneurysm 60 NR NR
28), aneurysm (39),
urysm (4)
60 25 NR
ction, aneurysm, pseudoaneurysm,
chial fistula; elective (19), urgent (9),
/28 were arch repairs, not included
63 32 NR
57), dissection (82), penetrating
psuedoaneurysm (26), trauma (11),
chial fistula (9); elective (224), urgent
72 38 36
rgent 29 0 NR
6), thoracoabdominal aneurysm (22),
c syndrome (19), dissection (52),
); elective (173), urgent (63)
64 NR 23
7), dissection (16), transection (4),
eurysm (2), right subclavian
(1); 5 had patent LIMA; 47 elective
ergent operations
67 24 63sm, tr
ve (1
m, di
aneur
t (7)
; all u
; all u
; all u
m, tr
on (1
oane
disse
bron
that 4
ta
sm (1
(34),
bron
)
; all u
sm (6
aorti
a (21
sm (4
doan
rysm
3 emthe descending thoracic aorta. We found very-low-quality
hypert
ve stu
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ischemia and vertebrobasilar ischemia with a strong trend
for increased risk of spinal cord ischemia and anterior
Table I. Continued
% HTN % Renal failure % Previous stroke % DM
NR NR NR NR
NR NR NR NR
NR NR NR NR
NR NR NR NR
NR NR NR NR
NR NR NR NR
NR NR NR NR
NR NR NR NR
NR NR NR NR
87 17 10 11
NR NR NR NR
58 25 NR NR
77 21 NR 19
CAD, Coronary artery disease; DM, diabetes mellitus; FP, for profit;HTN,
observational or nonrandomized study; P, prospective study; R, retrospecti
Fig 2. Arm ischemia: random-effects meta-analysis. S
confidence intervals, diamond represents the pooled effec
of the pooled estimate.circulation stroke. We found no difference in other out-comes such as death, myocardial infarction, or TIA. The
incidence of phrenic nerve injury associated with primary
revascularization was fairly low. Data on perioperative in-
F/U (Months) % Loss to F/U Funding Design*
UC NR NR OB, P, S
28 NR NR OB, R, S
UC 3 NR OB, R, S
17 NR NR OB, R, S
UC NR NR OB, R, S
44 NR NFP OB, R, S
19 NR NFP OB, R, S
NR NR NR OB, R, S
7 NR NFP OB, R, S
20 NR NFP OB, R, S
12 0 NFP OB, R, S
5 10 FP OB, R, M
11 NR NR OB, R, S
ension;M, multi-center study; NFP, not-for-profit;NR, not reported; OB,
dy; S, single center study; UC, unclear.
s are odds ratios of individual studies, lines are 95%
the width of the diamond is the 95% confidence intervalquare
t, andfection were sparse and inconclusive.
effe
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several reasons. First, the included studies are observa-
tional; hence, patients were assigned to the different inter-
Fig 3. Vertebrobasilar ischemia: random-effects meta-a
95% confidence intervals, diamond represents the pooled
interval of the pooled estimate.
Fig 4. Spinal cord ischemia: random-effects meta-analy
confidence intervals, diamond represents the pooled effec
of the pooled estimate.
Fig 5. Anterior circulation stroke: random-effects meta-
95% confidence intervals, diamond represents the pooled
interval of the pooled estimate.ventions based on their morbidity and surgeon’s preferences/expertise. Second, it is apparent that the patients within
each study are heterogenous in terms of diagnoses, mor-
bidity, and aortic pathology. It is possible that the under-
is. Squares are odds ratios of individual studies, lines are
ct, and the width of the diamond is the 95% confidence
uares are odds ratios of individual studies, lines are 95%
the width of the diamond is the 95% confidence interval
sis. Squares are odds ratios of individual studies, lines are
ct, and the width of the diamond is the 95% confidencenalys
effesis. Sq
t, andanalylying aortic pathology, rather than the procedure itself, had
CI, Confidence interval; OR, odds ratio; TIA, transient ischemic attack.
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are in general sparse with low number of events. Fourth, the
outcomes were poorly described in many cases; therefore,
transient or less clinically important outcomes (eg, a case of
hand ischemia that is not severe or does not require revas-
cularization) may have been included in the analysis, add-
ing an element of indirectness to this evidence. Thus, the
quality of the evidence is downgraded due to methodolog-
ical limitations of included studies, heterogeneity, impreci-
sion, and indirectness.
Strengths, limitations, and comparison with other
systematic reviews
A systematic review and meta-analysis conducted by
Cooper et al16 found that LSA coverage, with or without
revascularization, was associated with increased risk of
stroke, whereas the risk of spinal cord ischemia is only
increased when revascularization is not done. In this report,
we differentiated between anterior circulation stroke, tran-
sient ischemic attacks and vertebrobasilar ischemia; and
assessed several additional outcomes such as arm ischemia,
death, and myocardial infarction. Our findings are also in
agreement with a narrative review by Noor et al;17 our
review, however, explicitly describes the search process as
well as the eligibility criteria and offers a meta-analytic
estimate to assist decision makers in balancing the risks and
benefits of this procedure. In addition to these strengths,
our team reviewed evidence in blinded pairs of reviewers
with adequate inter-reviewer agreement. Also, we have
shown that our findings are robust to the use of different
statistical pooling methods and consistent across several
subgroups of patients, interventions, and study designs.
The inferences drawn are weak given the very low quality of
the best available evidence. Indeed, the primary studies
summarized here enrolled a heterogeneous patient popu-
lation, have important methodological limitations, and re-
port inconsistent findings. Furthermore, the overall data is
sparse and the estimates imprecise even after pooling.
Implications for practice and research
The increased risk of arm ischemia, vertebrobasilar
ischemia and, possibly, spinal cord ischemia and anterior
underwent LSA coverage
neurysm Dissection Trauma
/82 (2%) 7/127 (6%) 5/57 (9%)
NR NR NR
/82 (1%) 6/127 (5%) 1/47 (2%)
/26 (4%) 3/99 (3%) NR
/18 (11%) 1/60 (2%) 4/50 (8%)
not well-reported.Table II. Baseline risk of outcomes of interest in patients who
Outcome Overall risk A
Arm ischemia 38/687 (6%) 2
Spinal cord ischemia 27/673 (4%)
Vertebrobasilar ischemia 7/442 (2%) 1
Anterior circulation stroke 33/676 (5%) 1
Death 29/447 (6%) 2
LSA, Left subclavian artery; NR, no events reported/incalculable.
Data on myocardial infarction, infection, transient ischemic attacks are sparse andTable III. Subgroup analyses
Outcome Peto OR (95% CI)
P value for
interaction
Death
Control group:
revascularization
0.76 (0.18-3.29) .50
Control group: no
coverage
1.43 (0.46-4.42)
Elective procedure 327.20 (0.28-) .61
Urgent procedure 38.74 (0.61-)
Indication: aneurysm 1.25 (0.05-30.93) .78
Indication: dissection 2.41 (0.10-56.32)
Arm ischemia
Control group:
revascularization
3.05 (0.26-35.99) .01
Control group: no
coverage
144.43 (27.86-748.08)
Elective procedure 0.87 (0.24-3.19) .31
Urgent procedure 2.36 (0.55-10.09)
Indication: aneurysm 786.70 (1.08-) .79
Indication: dissection 3156.10 (1.23-)
Anterior circulation stroke
Control group:
revascularization
1.84 (0.35-9.74) .59
Control group: no
coverage
3.48 (0.72-16.67)
Elective procedure 1.44 (0.10-21.43) .65
Urgent procedure 0.28 (0.00-228.00)
Indication: aneurysm 1.39 (0.11-16.87) .31
Indication: dissection 7.68 (0.85-69.55)
TIA
Control group:
revascularization
0.58 (0.05-7.44) .59
Control group: no
coverage
1.53 (0.14-17.13)
Vertebrobasilar insufficiency
Control group:
revascularization
7.73 (1.54-38.68) .67
Control group: no
coverage
17.02 (2.58-112.14)
Indication: aneurysm 25.79 (0.16-) .92
Indication: dissection 19.18 (1.45-254.21)
Spinal cord ischemia
Control group:
revascularization
3.38 (0.64-18.02) .74
Control group: no
coverage
1.57 (0.14-18.27)
Indication: aneurysm 0.31 (0.01-18.98) .59
Indication: dissection 0.06 (0.00-3.63)circulation stroke associated with LSA coverage need to be
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repair, availability of surgical expertise, feasibility of carotid-
subclavian bypass or transposition before coverage, patient
anatomy, and other risks and burdens associated with these
procedures. The accompanying guideline document pre-
pared by the Committee on Thoracic Aortic disease from
the Society for Vascular Surgery contains the practical and
clinical implications of our results.
Considering that some of the indications for these
procedures, such as dissection or transsection, are rare and
data is overall sparse, it is apparent that future studies are
needed to confirm or dispute the weak inferences we have
drawn from the available very-low-quality evidence. Multi-
center research with collaboration among surgeons and
researchers is paramount to accrue the large number of
patients and events necessary to improve the precision of
future studies and the overall evidence base. Random or
protocol-driven allocation stratified by procedure urgency
and aortic pathology will decrease the heterogeneity of
future evidence and improve its quality.
CONCLUSION
Very low quality evidence suggests that the intentional
coverage of the left subclavian artery during placement of
an endovascular stent graft in the descending thoracic aorta
increases the risk of arm ischemia, vertebrobasilar ischemia,
and possibly of spinal cord ischemia and anterior circulation
stroke.When feasible, primary revascularization procedures
may reduce this risk.
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